References
Branford S (2016) Molecular monitoring in chronic myeloid leukemia—how low can you go? Hematol Am Soc Hematol Educ Program 2016:156–163
Cross NC, White HE, Colomer D et al (2015) Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia. Leukemia 29:999–1003
Foroni L, Wilson G, Gerrard G et al (2013) Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. Br J Haematol 153:179–190
www.met.ie. Accessed 11th April 2018
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from participants at the referring centers.
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Langabeer, S.E., Crampe, M. & Durney, T. The impact of sample processing delay on deep molecular responses in chronic myeloid leukemia. Ir J Med Sci 188, 351–352 (2019). https://doi.org/10.1007/s11845-018-1838-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-018-1838-6